share_log

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA将参加于10月16日周三举行的2024年Maxim Healthcare虚拟峰会
Accesswire ·  2024/10/15 22:30

STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit. Maxim Group LLC is presenting the virtual summit from October 15th to 17th.

2024年10月15日,纽约斯托尼布鲁克/ACCESSWIRE/ applied dna sciences股份有限公司(纳斯达克股票代码:APDN)("应用DNA"),一家PCR基因技术领军企业,今天宣布,首席执行官詹姆斯·A·海沃德博士将参加2024麦斯姆保健虚拟峰会上的炉边聊天。麦斯姆集团LLC将于10月15日至17日举办此虚拟峰会。

Jason McCarthy, Ph.D., Maxim's senior managing director and head of Biotechnology Research, will interview Dr. Hayward.Applied DNA's fireside chat will be available for viewing by registered conference attendees on Wednesday, October 16, 2024.

麦斯姆生物技术研究负责人,具有博士学位的詹森·麦卡锡将采访海沃德博士。应用DNA的炉边聊天将于2024年10月16日星期三提供给注册参会者观看。

Details for the fireside chat are as follows:
Date: Wednesday, October 16, 2024
Time: 12:50 p.m. EDT
Presenter: James A. Hayward, president and chief executive officer of Applied DNA
Registration: link

炉边聊天详情如下:
日期: 2024年10月16日,星期三
时间:下午12:50 EDT
演讲者:詹姆斯·A·海沃德,应用DNA总裁兼首席执行官
注册:链接

About Applied DNA Sciences

关于Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

applied dna sciences是一家生物技术公司,开发技术用于生产和检测脱氧核糖核酸("DNA")。利用聚合酶链反应("PCR")实现DNA的生产和检测,我们在三个主要业务市场运营:(i)在合成DNA的酶法制造方面用于核酸类治疗药物的生产,并开发和销售用于mRNA治疗药物生产的专有RNA聚合酶("RNAP");(ii)在分子诊断和遗传检测服务中检测DNA和RNA;以及(iii)用于工业供应链安全服务的DNA的制造和检测。

Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.

请访问adnas.com了解更多信息。关注我们的X和领英。加入我们的邮件列表。

Contacts:

联系人:

Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web:
X: @APDN

投资者关系联系人:Sanjay M. Hurry,917-733-5573,sanjay.hurry@adnas.com
网站:
X:@APDN

SOURCE: Applied DNA Sciences

来源:applied dna sciences


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发